학술논문
Utilizing PK and PD Biomarkers to Guide the First-in-Human Starting Dose Selection of MTBT1466A: A Novel Humanized Monoclonal Anti-TGFβ3 Antibody for the Treatment of Fibrotic Diseases
Document Type
Article
Author
Source
In: Journal of Pharmaceutical Sciences . (Journal of Pharmaceutical Sciences, November 2023, 112(11):2910-2920)
Subject
Language
English
ISSN
15206017
00223549
00223549